NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $34.78 million. The enterprise value is $39.67 million.

Market Cap	34.78M
Enterprise Value	39.67M

Important Dates

The next confirmed earnings date is Monday, March 17, 2025, before market open.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

NRXP has 16.88 million shares outstanding. The number of shares has increased by 32.95% in one year.

Current Share Class	16.88M
Shares Outstanding	16.88M
Shares Change (YoY)	+32.95%
Shares Change (QoQ)	+4.34%
Owned by Insiders (%)	11.27%
Owned by Institutions (%)	6.23%
Float	13.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-1.87
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-66.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-145.66%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	129.29%
Revenue Per Employee	n/a
Profits Per Employee	-$10.19M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.44% in the last 52 weeks. The beta is 1.22, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	-52.44%
50-Day Moving Average	2.95
200-Day Moving Average	2.18
Relative Strength Index (RSI)	38.85
Average Volume (20 Days)	215,285

Short Selling Information

The latest short interest is 1.15 million, so 6.82% of the outstanding shares have been sold short.

Short Interest	1.15M
Short Previous Month	1.03M
Short % of Shares Out	6.82%
Short % of Float	8.23%
Short Ratio (days to cover)	2.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.48M
Pretax Income	-25.64M
Net Income	-20.39M
EBITDA	-20.47M
EBIT	-20.48M
Earnings Per Share (EPS)	-$2.12

Full Income Statement

Balance Sheet

The company has $1.65 million in cash and $6.04 million in debt, giving a net cash position of -$4.39 million or -$0.26 per share.

Cash & Cash Equivalents	1.65M
Total Debt	6.04M
Net Cash	-4.39M
Net Cash Per Share	-$0.26
Equity (Book Value)	-18.82M
Book Value Per Share	-1.66
Working Capital	-16.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.73 million and capital expenditures $1,000, giving a free cash flow of -$11.73 million.

Operating Cash Flow	-11.73M
Capital Expenditures	1,000
Free Cash Flow	-11.73M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.95%
Shareholder Yield	-32.95%
Earnings Yield	-57.79%
FCF Yield	-33.24%

Analyst Forecast

The average price target for NRXP is $31.67, which is 1,437.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.67
Price Target Difference	1,437.38%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1